((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
| Price | USD1.00 |
| Packge | 1g |
- Min. Order:1g
- Supply Ability:10000KGS
- Time:2020-01-15
Product Details
- Product Name((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
- CAS No.1132709-15-9
- MFC19H25BN4O4
- MW384.24
- AppearanceSolidWhite to Off-White
- density 1.214±0.06 g/cm3(Predicted)
- storage temp. under inert gas (nitrogen or Argon) at 2-8°C
Contact:hanne
email:hanne@coreychem.com
wechat/whatsapp:+8615670622393
hanne 7
▼
▲
Product Name:
Synonyms:
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid;(1R,2R)-BortezoMib;[(1R)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;Bortezomib impurity 1/(1R,2R)-Bortezomib;[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride;(1R,2R)-Bortezomib Impurity;[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
CAS:
MF:
C19H25BN4O4
MW:
384.2372
EINECS:
Product Categories:
Mol File:
▼
▲
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid Chemical Properties
▼
▲
density
1.214±0.06 g/cm3(Predicted)
pka
9.66±0.43(Predicted)
▼
▲
Safety Information
▼
▲
▼
▲
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid Usage And Synthesis
▼
▲
Uses
(1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
-
VIP3年
- GLP Pharma Standards
- Bortezomib Impurity (R,R-Isomer)/Bortezomib Related compound A NLT 95%
- Inquiry
- 2026-02-03
-
VIP0年
- GLP Pharma Standards
- Bortezomib Impurity (R,R-Isomer)/Bortezomib Related compound A NLT 95%
- Inquiry
- 2026-02-03
-
VIP1年
- SYNTHENTA PVT LTD
- (S)-2-Amino-N-((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)-3-methylbutanamide 97-99%
- Inquiry
- 2026-01-02
-
VIP3年
- ALS India Life Sciences
- 1-(2-Bromophenyl)-3-{(3S)-1-[5-(trifluoromethyl)-2-pyridinyl]-3-pyrrolidinyl}urea 95.00%
- Inquiry
- 2025-05-26
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY